× schließen

HIV

MSF South Africa HIV

    10. Abongomera C, Diro E, de Lima Pereira A, Buyze J, Stille K, Ahmed F, et al. The initial effectiveness of liposomal amphotericin B (AmBisome) and miltefosine combination for treatment of visceral leishmaniasis in HIV co-infected patients in Ethiopia: A retrospective cohort study. PLoS Negl Trop Dis. 2018; 12(5): e0006527.

    11. Chihana ML, Huerga H, Van Cutsem G, Ellman T, Wanjala S, Masiku C, et al. Impact of "test and treat" recommendations on eligibility for antiretroviral treatment: Cross sectional population survey data from three high HIV prevalence countries. PLoS One. 2018; 13(11): e0207656.

    12. Etoori D, Ciglenecki I, Ndlangamandla M, Edwards CG, Jobanputra K, Pasipamire M, et al. Successes and challenges in optimizing the viral load cascade to improve antiretroviral therapy adherence and rationalize second-line switches in Swaziland. J Int AIDS Soc. 2018; 21(10): e25194.

    13. Ford N, Meintjes G, Calmy A, Bygrave H, Migone C, Vitoria M, et al. Managing Advanced HIV Disease in a Public Health Approach. Clin Infect Dis. 2018; 66(suppl_2): S106-SS10.

    14. Gils T, Bossard C, Verdonck K, Owiti P, Casteels I, Mashako M, et al. Stockouts of HIV commodities in public health facilities in Kinshasa: Barriers to end HIV. PLoS One. 2018; 13(1): e0191294.

    15. Grebe E, Welte A, Johnson LF, van Cutsem G, Puren A, Ellman T, et al. Population-level HIV incidence estimates using a combination of synthetic cohort and recency biomarker approaches in KwaZulu-Natal, South Africa. PLoS One. 2018; 13(9): e0203638.

    16. Grimsrud A, Bygrave H, Wilkinson L. The Case For Family-Centered Differentiated Service Delivery for HIV. J Acquir Immune Defic Syndr. 2018; 78 Suppl 2: S124-S7.

    17. Hu J, Geldsetzer P, Steele SJ, Matthews P, Ortblad K, Solomon T, et al. The impact of lay counselors on HIV testing rates: quasi-experimental evidence from lay counselor redeployment in KwaZulu-Natal, South Africa. Aids. 2018; 32(14): 2067-73.

    18. Huerga H, Van Cutsem G, Ben Farhat J, Puren A, Bouhenia M, Wiesner L, et al. Progress towards the UNAIDS 90-90-90 goals by age and gender in a rural area of KwaZulu-Natal, South Africa: a household-based community cross-sectional survey. BMC Public Health. 2018; 18(1): 303.

    19. Kaung Nyunt KK, Han WW, Satyanarayana S, Isaakidis P, Hone S, Khaing AA, et al. Factors associated with death and loss to follow-up in children on antiretroviral care in Mingalardon Specialist Hospital, Myanmar, 2006-2016. PLoS One. 2018; 13(4): e0195435.

    20. Kumar S, Gupte HA, Isaakidis P, Mishra JK, Munjattu JF. "They don't like us....": Barriers to antiretroviral and opioid substitution therapy among homeless HIV positive people who inject drugs in Delhi: A mixed method study. PLoS One. 2018; 13(8): e0203262.

    21. Osler M, Hilderbrand K, Goemaere E, Ford N, Smith M, Meintjes G, et al. The Continuing Burden of Advanced HIV Disease Over 10 Years of Increasing Antiretroviral Therapy Coverage in South Africa. Clin Infect Dis. 2018; 66(suppl_2): S118-S25.

    22. Ousley J, Niyibizi AA, Wanjala S, Vandenbulcke A, Kirubi B, Omwoyo W, et al. High Proportions of Patients With Advanced HIV Are Antiretroviral Therapy Experienced: Hospitalization Outcomes From 2 Sub-Saharan African Sites. Clin Infect Dis. 2018; 66(suppl_2): S126-S31.

    23. Patten G, Bernheimer J, Fairlie L, Rabie H, Sawry S, Technau K, et al. Lamivudine monotherapy as a holding regimen for HIV-positive children. PLoS One. 2018; 13(10): e0205455.

    24. Thomson KA, Telfer B, Opondo Awiti P, Munge J, Ngunga M, Reid A. Navigating the risks of prevention of mother to child transmission (PMTCT) of HIV services in Kibera, Kenya: Barriers to engaging and remaining in care. PLoS One. 2018; 13(1): e0191463.